Entering the Final Spurt: SYSCID Project Hosts International Symposium in Kiel and Launches New Interview Series
It’s been a busy past few weeks for the SYSCID team as the project is wrapping up its activities this month. From 29-30 August 2022, the team hosted the international symposium “Multi-omics of Chronic Inflammatory Diseases. From molecular signatures to novel clinical diagnostics” in Kiel, Germany. Representing the final gathering of the SYSCID consortium, the 1 ½ day symposium featured several high-class talks covering topics such as emerging technologies, integrated multi-omics of large human cohorts, or clinical epigenomics and inflammation.
“It was a great pleasure to celebrate the final stretch of SYSCID with leading experts in the field of CID from all over Europe and the US. We enjoyed the vivid scientific discussion of our findings after two long years of limited personal contacts,” concluded the SYSCID coordinator Prof. Philip Rosenstiel at the end of the conference.
SYSCID has aimed to integrate multiple omics layers and to create multidimensional predictive models with a strong emphasis on longitudinal prospective observations and single-cell level understanding.
On the occasion of the Symposium in Kiel, the team has also launched an interview series featuring different consortium members who reflect on the project's main project activities and achievements. Sharing their thoughts and views, all interviewees agree on the necessary steps forward, as summarised by Philip Rosenstiel: “The field of personalised medicine has to evolve in a manner that it really goes to the clinic.”
The interview series was planned and produced by the Eurice Communications team in cooperation with a filming company.
Watch the interview series here.